Edition:
United States

People: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

2.15CAD
22 Jul 2016
Change (% chg)

$0.08 (+3.86%)
Prev Close
$2.07
Open
$2.07
Day's High
$2.15
Day's Low
$2.07
Volume
1,483
Avg. Vol
25,584
52-wk High
$3.87
52-wk Low
$0.89

Rusaw, Nicole 

Ms. Nicole Rusaw, C.A., is Chief Financial Officer of Transition Therapeutics Inc. Ms. Rusaw has been with the Company since 2005 and was appointed as Chief Financial Officer in December 2011. While at Transition, Ms. Rusaw has been responsible for a broad range of activities with a focus on financial reporting and regulatory compliance as well as involvement in various equity financings and strategic acquisitions.

Basic Compensation

Total Annual Compensation, CAD 222,480
Restricted Stock Awards, CAD --
Long-Term Incentive Plans, CAD --
All Other, CAD 93,574
Fiscal Year Total, CAD 316,054

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tony Cruz

424,876

Carl Damiani

199,228

Nicole Rusaw

316,054

Bruce Connop

287,182

Aleksandra Pastrak

407,711

Louis Alexopoulos

--
As Of  29 Jun 2013